

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 4.82534662 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 4.13319407 |
| 3 | Golgi transport vesicle coating (GO:0048200) | 4.13319407 |
| 4 | detection of other organism (GO:0098543) | 4.06806826 |
| 5 | glycosphingolipid catabolic process (GO:0046479) | 4.05722481 |
| 6 | axonemal dynein complex assembly (GO:0070286) | 3.83876573 |
| 7 | detection of bacterium (GO:0016045) | 3.78313887 |
| 8 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.68882080 |
| 9 | detection of external biotic stimulus (GO:0098581) | 3.68809245 |
| 10 | cellular extravasation (GO:0045123) | 3.63587345 |
| 11 | glycolipid catabolic process (GO:0019377) | 3.63058215 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.59581496 |
| 13 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.54178525 |
| 14 | apoptotic cell clearance (GO:0043277) | 3.49364575 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.49259908 |
| 16 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.47325484 |
| 17 | negative regulation of cell killing (GO:0031342) | 3.47325484 |
| 18 | keratan sulfate catabolic process (GO:0042340) | 3.47183329 |
| 19 | oligosaccharide catabolic process (GO:0009313) | 3.43767839 |
| 20 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.43345929 |
| 21 | regulation of tolerance induction (GO:0002643) | 3.41571123 |
| 22 | amino sugar catabolic process (GO:0046348) | 3.40139320 |
| 23 | collagen fibril organization (GO:0030199) | 3.36047550 |
| 24 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.32073459 |
| 25 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.28805779 |
| 26 | detection of biotic stimulus (GO:0009595) | 3.27772429 |
| 27 | protein heterotrimerization (GO:0070208) | 3.24210540 |
| 28 | ceramide catabolic process (GO:0046514) | 3.22618965 |
| 29 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.22209285 |
| 30 | granulocyte activation (GO:0036230) | 3.22050332 |
| 31 | cell adhesion mediated by integrin (GO:0033627) | 3.21536721 |
| 32 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.21215561 |
| 33 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.17603484 |
| 34 | chondrocyte proliferation (GO:0035988) | 3.15771416 |
| 35 | regulation of mast cell degranulation (GO:0043304) | 3.11985734 |
| 36 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.11225401 |
| 37 | endodermal cell differentiation (GO:0035987) | 3.09844792 |
| 38 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.09146637 |
| 39 | macrophage activation (GO:0042116) | 3.08627085 |
| 40 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.07788409 |
| 41 | cellular response to type I interferon (GO:0071357) | 3.07051671 |
| 42 | type I interferon signaling pathway (GO:0060337) | 3.07051671 |
| 43 | wound healing, spreading of epidermal cells (GO:0035313) | 3.05132714 |
| 44 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.04530358 |
| 45 | regulation of integrin activation (GO:0033623) | 3.04348907 |
| 46 | response to type I interferon (GO:0034340) | 3.03758248 |
| 47 | response to thyroid hormone (GO:0097066) | 3.03270375 |
| 48 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.01731322 |
| 49 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.01731322 |
| 50 | modulation by symbiont of host immune response (GO:0052553) | 3.01731322 |
| 51 | positive regulation by symbiont of host defense response (GO:0052509) | 3.01731322 |
| 52 | modulation by symbiont of host defense response (GO:0052031) | 3.01731322 |
| 53 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.01731322 |
| 54 | neutrophil activation (GO:0042119) | 3.00468894 |
| 55 | T-helper 1 type immune response (GO:0042088) | 2.98786056 |
| 56 | protein retention in ER lumen (GO:0006621) | 2.98343201 |
| 57 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.97398731 |
| 58 | basement membrane organization (GO:0071711) | 2.97044782 |
| 59 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.96114552 |
| 60 | skin morphogenesis (GO:0043589) | 2.95517674 |
| 61 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.95450259 |
| 62 | myeloid cell activation involved in immune response (GO:0002275) | 2.95327642 |
| 63 | regulation of leukocyte degranulation (GO:0043300) | 2.95212734 |
| 64 | positive regulation of mast cell activation (GO:0033005) | 2.92889581 |
| 65 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.92736141 |
| 66 | peptide catabolic process (GO:0043171) | 2.92573659 |
| 67 | response to muramyl dipeptide (GO:0032495) | 2.92452668 |
| 68 | positive regulation of tolerance induction (GO:0002645) | 2.92052606 |
| 69 | positive regulation of leukocyte degranulation (GO:0043302) | 2.91658414 |
| 70 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.91144064 |
| 71 | regulation of mitotic spindle organization (GO:0060236) | 2.89140606 |
| 72 | positive regulation of type 2 immune response (GO:0002830) | 2.85268693 |
| 73 | positive regulation of antigen processing and presentation (GO:0002579) | 2.84634656 |
| 74 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.84047238 |
| 75 | reactive oxygen species biosynthetic process (GO:1903409) | 2.83711600 |
| 76 | germinal center formation (GO:0002467) | 2.83193102 |
| 77 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.83081185 |
| 78 | regulation of antigen processing and presentation (GO:0002577) | 2.81544333 |
| 79 | respiratory burst (GO:0045730) | 2.80780667 |
| 80 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.80632034 |
| 81 | positive regulation of mast cell degranulation (GO:0043306) | 2.80632034 |
| 82 | regulation of macrophage chemotaxis (GO:0010758) | 2.80530941 |
| 83 | microglial cell activation (GO:0001774) | 2.79738143 |
| 84 | response to xenobiotic stimulus (GO:0009410) | 2.79315705 |
| 85 | cellular response to interferon-alpha (GO:0035457) | 2.79182070 |
| 86 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.78967490 |
| 87 | low-density lipoprotein particle clearance (GO:0034383) | 2.78949404 |
| 88 | paraxial mesoderm development (GO:0048339) | 2.78881704 |
| 89 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.78290690 |
| 90 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.78205774 |
| 91 | N-acetylneuraminate metabolic process (GO:0006054) | 2.77777221 |
| 92 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.77010735 |
| 93 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.76657503 |
| 94 | response to host immune response (GO:0052572) | 2.76657503 |
| 95 | eosinophil chemotaxis (GO:0048245) | 2.75617467 |
| 96 | regulation of podosome assembly (GO:0071801) | 2.75360020 |
| 97 | regulation of superoxide anion generation (GO:0032928) | 2.74271595 |
| 98 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.71441729 |
| 99 | cellular response to vitamin (GO:0071295) | 2.71166198 |
| 100 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.70896594 |
| 101 | regulation of mononuclear cell migration (GO:0071675) | 2.69588462 |
| 102 | regulation of T cell tolerance induction (GO:0002664) | 2.69527262 |
| 103 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.69340399 |
| 104 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.69260877 |
| 105 | barbed-end actin filament capping (GO:0051016) | 2.67589272 |
| 106 | membrane lipid catabolic process (GO:0046466) | 2.67528792 |
| 107 | positive regulation of interferon-alpha production (GO:0032727) | 2.67216877 |
| 108 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.66384353 |
| 109 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.66129345 |
| 110 | sphingolipid catabolic process (GO:0030149) | 2.65243113 |
| 111 | wound healing, spreading of cells (GO:0044319) | 2.63918969 |
| 112 | regulation of mast cell activation (GO:0033003) | 2.63775505 |
| 113 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.62915086 |
| 114 | cellular response to interferon-gamma (GO:0071346) | 2.62460516 |
| 115 | positive regulation of nuclease activity (GO:0032075) | 2.62411481 |
| 116 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.61819510 |
| 117 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.60822077 |
| 118 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.59801858 |
| 119 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.59783137 |
| 120 | myeloid dendritic cell differentiation (GO:0043011) | 2.59348922 |
| 121 | regulation of gamma-delta T cell activation (GO:0046643) | 2.57339828 |
| 122 | negative regulation of fatty acid transport (GO:2000192) | 2.55437796 |
| 123 | regulation of spindle organization (GO:0090224) | 2.55067275 |
| 124 | protein localization to kinetochore (GO:0034501) | 2.53411857 |
| 125 | immunoglobulin mediated immune response (GO:0016064) | 2.52943329 |
| 126 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.52198573 |
| 127 | regulation of interferon-alpha production (GO:0032647) | 2.49877982 |
| 128 | regulation of nuclease activity (GO:0032069) | 2.49129200 |
| 129 | folic acid transport (GO:0015884) | 2.46830880 |
| 130 | neutrophil activation involved in immune response (GO:0002283) | 2.46563278 |
| 131 | collagen metabolic process (GO:0032963) | 2.46233388 |
| 132 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.46129715 |
| 133 | cellular response to unfolded protein (GO:0034620) | 2.45585669 |
| 134 | mitotic nuclear envelope disassembly (GO:0007077) | 2.45549848 |
| 135 | detection of molecule of bacterial origin (GO:0032490) | 2.43460924 |
| 136 | heterochromatin organization (GO:0070828) | 2.39934406 |
| 137 | collagen catabolic process (GO:0030574) | 2.39381312 |
| 138 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.37423400 |
| 139 | myeloid cell homeostasis (GO:0002262) | 2.36962186 |
| 140 | cellular response to topologically incorrect protein (GO:0035967) | 2.36438320 |
| 141 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.35681964 |
| 142 | macrophage activation involved in immune response (GO:0002281) | 2.35205642 |
| 143 | regulation of protein import into nucleus, translocation (GO:0033158) | 2.33744506 |
| 144 | B cell mediated immunity (GO:0019724) | 2.32185995 |
| 145 | regulation of gene silencing by RNA (GO:0060966) | 2.32185142 |
| 146 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.32185142 |
| 147 | regulation of gene silencing by miRNA (GO:0060964) | 2.32185142 |
| 148 | hyaluronan catabolic process (GO:0030214) | 2.31996729 |
| 149 | peptidyl-proline hydroxylation (GO:0019511) | 2.31693607 |
| 150 | cellular response to vitamin D (GO:0071305) | 2.31240087 |
| 151 | nuclear envelope disassembly (GO:0051081) | 2.30364519 |
| 152 | membrane disassembly (GO:0030397) | 2.30364519 |
| 153 | regulation of cholesterol storage (GO:0010885) | 2.30223643 |
| 154 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.29769880 |
| 155 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.29591128 |
| 156 | natural killer cell mediated immunity (GO:0002228) | 2.29591128 |
| 157 | negative regulation of interleukin-12 production (GO:0032695) | 2.29018699 |
| 158 | nuclear pore organization (GO:0006999) | 2.27935908 |
| 159 | mannose metabolic process (GO:0006013) | 2.25551983 |
| 160 | regulation of protein heterodimerization activity (GO:0043497) | 2.25388315 |
| 161 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.25330926 |
| 162 | vagina development (GO:0060068) | 2.24114263 |
| 163 | T cell apoptotic process (GO:0070231) | 2.23971728 |
| 164 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.23876059 |
| 165 | positive regulation of interferon-beta production (GO:0032728) | 2.23832512 |
| 166 | pinocytosis (GO:0006907) | 2.23648137 |
| 167 | ER-nucleus signaling pathway (GO:0006984) | 2.23294364 |
| 168 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.22006913 |
| 169 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 2.21282315 |
| 170 | COPII vesicle coating (GO:0048208) | 2.19650735 |
| 171 | positive regulation of p38MAPK cascade (GO:1900745) | 2.16756288 |
| 172 | nuclear pore complex assembly (GO:0051292) | 2.16633185 |
| 173 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.16521735 |
| 174 | multicellular organismal catabolic process (GO:0044243) | 2.16391916 |
| 175 | extracellular matrix disassembly (GO:0022617) | 2.14965593 |
| 176 | formation of translation preinitiation complex (GO:0001731) | 2.14672497 |
| 177 | regulation of early endosome to late endosome transport (GO:2000641) | 2.14420843 |
| 178 | folic acid metabolic process (GO:0046655) | 2.13442846 |
| 179 | regulation of hippo signaling (GO:0035330) | 2.13319216 |
| 180 | multicellular organismal metabolic process (GO:0044236) | 2.13157232 |
| 181 | response to laminar fluid shear stress (GO:0034616) | 2.12811867 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.46352024 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.94891221 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.67979016 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.14573817 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.88332347 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.85871383 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.64108702 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.63267636 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.58047136 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.47333897 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.35468721 |
| 12 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.25803356 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.24715526 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.16040425 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.14979126 |
| 16 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.03242456 |
| 17 | * TFEB_21752829_ChIP-Seq_HELA_Human | 2.01940065 |
| 18 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.97198421 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.96851092 |
| 20 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.96433106 |
| 21 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.93817876 |
| 22 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.89802001 |
| 23 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.85312476 |
| 24 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.84578772 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.80226143 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.76731113 |
| 27 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.72470171 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71471635 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71445294 |
| 30 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.70181712 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.69245166 |
| 32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.69146255 |
| 33 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.67639880 |
| 34 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.67350281 |
| 35 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.66065612 |
| 36 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.63777095 |
| 37 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.63690816 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.61364930 |
| 39 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.61306729 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.56381467 |
| 41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.54701066 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.48905143 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48704923 |
| 44 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.48231042 |
| 45 | MAF_26560356_Chip-Seq_TH1_Human | 1.47588069 |
| 46 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46966496 |
| 47 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.46823347 |
| 48 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.46321083 |
| 49 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45378550 |
| 50 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.45275181 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43963250 |
| 52 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.42153292 |
| 53 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.42022480 |
| 54 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.39197012 |
| 55 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38548334 |
| 56 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.37932163 |
| 57 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37548898 |
| 58 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.36833605 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34711511 |
| 60 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.34566549 |
| 61 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.34473156 |
| 62 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.32312064 |
| 63 | * MYB_26560356_Chip-Seq_TH2_Human | 1.32003055 |
| 64 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.31887684 |
| 65 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.31771835 |
| 66 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.31664919 |
| 67 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.30678556 |
| 68 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30458331 |
| 69 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30406822 |
| 70 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.30306013 |
| 71 | ATF3_27146783_Chip-Seq_COLON_Human | 1.29897075 |
| 72 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29480583 |
| 73 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.29302439 |
| 74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28980818 |
| 75 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.28195829 |
| 76 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.26498602 |
| 77 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.26188232 |
| 78 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.26140996 |
| 79 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.25902800 |
| 80 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.24735056 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24350576 |
| 82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24110004 |
| 83 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.22763817 |
| 84 | MYC_22102868_ChIP-Seq_BL_Human | 1.22760774 |
| 85 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22559826 |
| 86 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22519584 |
| 87 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.21785679 |
| 88 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20230004 |
| 89 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19675221 |
| 90 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19315763 |
| 91 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19114616 |
| 92 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.18234529 |
| 93 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.17307529 |
| 94 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17147472 |
| 95 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16422912 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16399364 |
| 97 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16147244 |
| 98 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.15915749 |
| 99 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15560958 |
| 100 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15421132 |
| 101 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.15298114 |
| 102 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.15033382 |
| 103 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.14442270 |
| 104 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.14078323 |
| 105 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.13679156 |
| 106 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12831786 |
| 107 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.12769689 |
| 108 | MYB_26560356_Chip-Seq_TH1_Human | 1.11460707 |
| 109 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11327842 |
| 110 | UTX_26944678_Chip-Seq_JUKART_Human | 1.10371666 |
| 111 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.10297019 |
| 112 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.09768389 |
| 113 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.09768389 |
| 114 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.09768389 |
| 115 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.09726313 |
| 116 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.09651821 |
| 117 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.09592298 |
| 118 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09414817 |
| 119 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.09122117 |
| 120 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.07912329 |
| 121 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07480323 |
| 122 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06706325 |
| 123 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06542567 |
| 124 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.06534842 |
| 125 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.06491218 |
| 126 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.06491218 |
| 127 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.05682322 |
| 128 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.04981718 |
| 129 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.04099154 |
| 130 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04041311 |
| 131 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03911299 |
| 132 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03303276 |
| 133 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03162593 |
| 134 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.02959454 |
| 135 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02910371 |
| 136 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02733012 |
| 137 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01269709 |
| 138 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.01233094 |
| 139 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00611601 |
| 140 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00600114 |
| 141 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00209607 |
| 142 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99868221 |
| 143 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.99617934 |
| 144 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99309225 |
| 145 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.98861468 |
| 146 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.98761817 |
| 147 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.98521379 |
| 148 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98490400 |
| 149 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98277269 |
| 150 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.98205002 |
| 151 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.97840832 |
| 152 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.97772504 |
| 153 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.97745221 |
| 154 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.96902401 |
| 155 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.96500451 |
| 156 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95539987 |
| 157 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.94962749 |
| 158 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.94492171 |
| 159 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.94200655 |
| 160 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.93280241 |
| 161 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.91370034 |
| 162 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.91096446 |
| 163 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.90964578 |
| 164 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.90078980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.57245824 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.78847688 |
| 3 | MP0003724_increased_susceptibility_to | 3.26723208 |
| 4 | MP0005275_abnormal_skin_tensile | 2.94415559 |
| 5 | MP0005058_abnormal_lysosome_morphology | 2.85646065 |
| 6 | MP0005503_abnormal_tendon_morphology | 2.79263166 |
| 7 | MP0005257_abnormal_intraocular_pressure | 2.51517741 |
| 8 | MP0002877_abnormal_melanocyte_morpholog | 2.46708002 |
| 9 | MP0005025_abnormal_response_to | 2.46382934 |
| 10 | MP0010352_gastrointestinal_tract_polyps | 2.29102190 |
| 11 | MP0003279_aneurysm | 2.25381398 |
| 12 | MP0005671_abnormal_response_to | 2.24305221 |
| 13 | MP0003566_abnormal_cell_adhesion | 2.21151117 |
| 14 | MP0010307_abnormal_tumor_latency | 2.08623890 |
| 15 | MP0003075_altered_response_to | 2.06569326 |
| 16 | MP0001958_emphysema | 2.06104188 |
| 17 | MP0001800_abnormal_humoral_immune | 1.94777820 |
| 18 | MP0002723_abnormal_immune_serum | 1.94449941 |
| 19 | MP0009840_abnormal_foam_cell | 1.92672361 |
| 20 | MP0000604_amyloidosis | 1.92399228 |
| 21 | MP0005023_abnormal_wound_healing | 1.89470751 |
| 22 | MP0005076_abnormal_cell_differentiation | 1.79800719 |
| 23 | MP0002420_abnormal_adaptive_immunity | 1.74777957 |
| 24 | MP0001819_abnormal_immune_cell | 1.74590064 |
| 25 | MP0008260_abnormal_autophagy | 1.70369423 |
| 26 | MP0003283_abnormal_digestive_organ | 1.68327591 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.66352625 |
| 28 | MP0006054_spinal_hemorrhage | 1.64948571 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.61477707 |
| 30 | MP0003828_pulmonary_edema | 1.61329071 |
| 31 | MP0003172_abnormal_lysosome_physiology | 1.61267875 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.56765836 |
| 33 | MP0001835_abnormal_antigen_presentation | 1.56421189 |
| 34 | MP0003436_decreased_susceptibility_to | 1.55461761 |
| 35 | MP0009764_decreased_sensitivity_to | 1.53244869 |
| 36 | MP0008469_abnormal_protein_level | 1.51445027 |
| 37 | MP0005508_abnormal_skeleton_morphology | 1.48065711 |
| 38 | MP0003448_altered_tumor_morphology | 1.42785981 |
| 39 | MP0000858_altered_metastatic_potential | 1.41011777 |
| 40 | MP0005451_abnormal_body_composition | 1.40723280 |
| 41 | MP0003091_abnormal_cell_migration | 1.39725372 |
| 42 | MP0008004_abnormal_stomach_pH | 1.39494338 |
| 43 | MP0005166_decreased_susceptibility_to | 1.34920096 |
| 44 | MP0003690_abnormal_glial_cell | 1.34487364 |
| 45 | MP0001542_abnormal_bone_strength | 1.33965363 |
| 46 | MP0005310_abnormal_salivary_gland | 1.33939520 |
| 47 | MP0008007_abnormal_cellular_replicative | 1.33901413 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.33655917 |
| 49 | MP0002132_abnormal_respiratory_system | 1.31926011 |
| 50 | MP0004272_abnormal_basement_membrane | 1.29923152 |
| 51 | MP0003693_abnormal_embryo_hatching | 1.27053931 |
| 52 | MP0005390_skeleton_phenotype | 1.26010376 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.25785926 |
| 54 | MP0002139_abnormal_hepatobiliary_system | 1.24839227 |
| 55 | MP0002295_abnormal_pulmonary_circulatio | 1.22003434 |
| 56 | MP0009384_cardiac_valve_regurgitation | 1.21282578 |
| 57 | MP0004510_myositis | 1.21044577 |
| 58 | MP0002060_abnormal_skin_morphology | 1.20488151 |
| 59 | MP0000716_abnormal_immune_system | 1.18454555 |
| 60 | MP0010234_abnormal_vibrissa_follicle | 1.18164989 |
| 61 | * MP0005164_abnormal_response_to | 1.16982562 |
| 62 | MP0001243_abnormal_dermal_layer | 1.15970089 |
| 63 | MP0000685_abnormal_immune_system | 1.15674941 |
| 64 | MP0000733_abnormal_muscle_development | 1.15167244 |
| 65 | MP0006082_CNS_inflammation | 1.14869225 |
| 66 | MP0005165_increased_susceptibility_to | 1.14072804 |
| 67 | MP0005623_abnormal_meninges_morphology | 1.13511577 |
| 68 | MP0003111_abnormal_nucleus_morphology | 1.12339411 |
| 69 | MP0001545_abnormal_hematopoietic_system | 1.11720103 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 1.11720103 |
| 71 | MP0003300_gastrointestinal_ulcer | 1.10017870 |
| 72 | MP0002933_joint_inflammation | 1.09589429 |
| 73 | MP0004957_abnormal_blastocyst_morpholog | 1.08157128 |
| 74 | MP0008875_abnormal_xenobiotic_pharmacok | 1.06722336 |
| 75 | MP0002419_abnormal_innate_immunity | 1.06308714 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 1.03895544 |
| 77 | MP0002168_other_aberrant_phenotype | 1.02440624 |
| 78 | MP0003186_abnormal_redox_activity | 1.02097729 |
| 79 | MP0003077_abnormal_cell_cycle | 1.01993652 |
| 80 | MP0005408_hypopigmentation | 1.01914264 |
| 81 | MP0002998_abnormal_bone_remodeling | 1.01898270 |
| 82 | MP0000371_diluted_coat_color | 1.01804171 |
| 83 | MP0009053_abnormal_anal_canal | 1.01004743 |
| 84 | MP0009763_increased_sensitivity_to | 0.99903407 |
| 85 | MP0001851_eye_inflammation | 0.99571796 |
| 86 | MP0003329_amyloid_beta_deposits | 0.98268800 |
| 87 | MP0000767_abnormal_smooth_muscle | 0.95295285 |
| 88 | MP0003303_peritoneal_inflammation | 0.95261215 |
| 89 | MP0004947_skin_inflammation | 0.94252237 |
| 90 | MP0002398_abnormal_bone_marrow | 0.93638088 |
| 91 | MP0000343_altered_response_to | 0.92870183 |
| 92 | MP0002896_abnormal_bone_mineralization | 0.92271058 |
| 93 | MP0009333_abnormal_splenocyte_physiolog | 0.92239964 |
| 94 | MP0010030_abnormal_orbit_morphology | 0.92150129 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 0.92148340 |
| 96 | MP0000689_abnormal_spleen_morphology | 0.91669518 |
| 97 | MP0002429_abnormal_blood_cell | 0.91560438 |
| 98 | MP0000350_abnormal_cell_proliferation | 0.91178325 |
| 99 | MP0003795_abnormal_bone_structure | 0.90396719 |
| 100 | MP0003806_abnormal_nucleotide_metabolis | 0.90225445 |
| 101 | MP0005000_abnormal_immune_tolerance | 0.89617104 |
| 102 | MP0005365_abnormal_bile_salt | 0.89545350 |
| 103 | MP0005387_immune_system_phenotype | 0.88768886 |
| 104 | MP0001790_abnormal_immune_system | 0.88768886 |
| 105 | MP0002148_abnormal_hypersensitivity_rea | 0.88418532 |
| 106 | MP0000920_abnormal_myelination | 0.87828258 |
| 107 | MP0003453_abnormal_keratinocyte_physiol | 0.87695763 |
| 108 | MP0001849_ear_inflammation | 0.86798553 |
| 109 | MP0001915_intracranial_hemorrhage | 0.86726843 |
| 110 | MP0009278_abnormal_bone_marrow | 0.85438640 |
| 111 | MP0002452_abnormal_antigen_presenting | 0.85331092 |
| 112 | * MP0004883_abnormal_blood_vessel | 0.84305024 |
| 113 | MP0003195_calcinosis | 0.81515652 |
| 114 | MP0002722_abnormal_immune_system | 0.81374651 |
| 115 | MP0005621_abnormal_cell_physiology | 0.79772253 |
| 116 | MP0005395_other_phenotype | 0.78306605 |
| 117 | MP0004019_abnormal_vitamin_homeostasis | 0.78267356 |
| 118 | MP0002166_altered_tumor_susceptibility | 0.76333033 |
| 119 | MP0000428_abnormal_craniofacial_morphol | 0.75792195 |
| 120 | MP0002115_abnormal_skeleton_extremities | 0.74995268 |
| 121 | MP0002138_abnormal_hepatobiliary_system | 0.74769769 |
| 122 | MP0009765_abnormal_xenobiotic_induced | 0.73014858 |
| 123 | MP0005197_abnormal_uvea_morphology | 0.72171648 |
| 124 | MP0003045_fibrosis | 0.71684509 |
| 125 | MP0010094_abnormal_chromosome_stability | 0.71320235 |
| 126 | MP0005167_abnormal_blood-brain_barrier | 0.70938653 |
| 127 | MP0003191_abnormal_cellular_cholesterol | 0.70646713 |
| 128 | MP0004197_abnormal_fetal_growth/weight/ | 0.70593436 |
| 129 | MP0002113_abnormal_skeleton_development | 0.69586669 |
| 130 | MP0001730_embryonic_growth_arrest | 0.69419166 |
| 131 | MP0000627_abnormal_mammary_gland | 0.68347254 |
| 132 | MP0002282_abnormal_trachea_morphology | 0.67480513 |
| 133 | MP0005319_abnormal_enzyme/_coenzyme | 0.67308158 |
| 134 | MP0002405_respiratory_system_inflammati | 0.66849669 |
| 135 | MP0000598_abnormal_liver_morphology | 0.66698793 |
| 136 | MP0001348_abnormal_lacrimal_gland | 0.66583714 |
| 137 | MP0002254_reproductive_system_inflammat | 0.65992560 |
| 138 | MP0001845_abnormal_inflammatory_respons | 0.65966259 |
| 139 | MP0002086_abnormal_extraembryonic_tissu | 0.65416344 |
| 140 | MP0002111_abnormal_tail_morphology | 0.65157018 |
| 141 | * MP0000249_abnormal_blood_vessel | 0.64497322 |
| 142 | MP0010678_abnormal_skin_adnexa | 0.64434294 |
| 143 | MP0002135_abnormal_kidney_morphology | 0.64068679 |
| 144 | MP0000163_abnormal_cartilage_morphology | 0.64037902 |
| 145 | MP0001175_abnormal_lung_morphology | 0.63624669 |
| 146 | MP0001216_abnormal_epidermal_layer | 0.63577190 |
| 147 | MP0000490_abnormal_crypts_of | 0.63567388 |
| 148 | MP0003763_abnormal_thymus_physiology | 0.63471958 |
| 149 | MP0009785_altered_susceptibility_to | 0.62378526 |
| 150 | MP0005384_cellular_phenotype | 0.62143847 |
| 151 | MP0000569_abnormal_digit_pigmentation | 0.62135131 |
| 152 | MP0009643_abnormal_urine_homeostasis | 0.61823789 |
| 153 | MP0001853_heart_inflammation | 0.61581438 |
| 154 | MP0008932_abnormal_embryonic_tissue | 0.61444970 |
| 155 | MP0003866_abnormal_defecation | 0.60269805 |
| 156 | MP0001663_abnormal_digestive_system | 0.60196361 |
| 157 | MP0002136_abnormal_kidney_physiology | 0.59717261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 6.00243523 |
| 2 | Premature rupture of membranes (HP:0001788) | 5.83056576 |
| 3 | Cervical subluxation (HP:0003308) | 4.66587352 |
| 4 | Vertebral compression fractures (HP:0002953) | 4.35653212 |
| 5 | Peritonitis (HP:0002586) | 4.35541968 |
| 6 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.30163988 |
| 7 | Loss of speech (HP:0002371) | 3.84880831 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.84155924 |
| 9 | Ankle contracture (HP:0006466) | 3.83205537 |
| 10 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.78977735 |
| 11 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.78977735 |
| 12 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.67984623 |
| 13 | Absent/shortened dynein arms (HP:0200106) | 3.64188008 |
| 14 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.64188008 |
| 15 | Abnormal ciliary motility (HP:0012262) | 3.59718138 |
| 16 | Nasal polyposis (HP:0100582) | 3.59065890 |
| 17 | Abnormality of the nasal mucosa (HP:0000433) | 3.46147944 |
| 18 | Rhinitis (HP:0012384) | 3.39923000 |
| 19 | Vacuolated lymphocytes (HP:0001922) | 3.36296475 |
| 20 | Dysostosis multiplex (HP:0000943) | 3.34586218 |
| 21 | Soft skin (HP:0000977) | 3.27343557 |
| 22 | Cerebral aneurysm (HP:0004944) | 3.25220160 |
| 23 | Shallow orbits (HP:0000586) | 3.12665427 |
| 24 | Increased cerebral lipofuscin (HP:0011813) | 3.08259851 |
| 25 | Mucopolysacchariduria (HP:0008155) | 3.07950074 |
| 26 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.07950074 |
| 27 | Osteolytic defects of the hand bones (HP:0009699) | 2.99634986 |
| 28 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.99634986 |
| 29 | Amyloidosis (HP:0011034) | 2.96570939 |
| 30 | Aortic dissection (HP:0002647) | 2.94966033 |
| 31 | Chronic bronchitis (HP:0004469) | 2.94895448 |
| 32 | Disinhibition (HP:0000734) | 2.94229823 |
| 33 | Mediastinal lymphadenopathy (HP:0100721) | 2.92073879 |
| 34 | Aortic aneurysm (HP:0004942) | 2.92043797 |
| 35 | Bronchiectasis (HP:0002110) | 2.89725351 |
| 36 | Biconcave vertebral bodies (HP:0004586) | 2.88595872 |
| 37 | Recurrent skin infections (HP:0001581) | 2.88509952 |
| 38 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.87894209 |
| 39 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.87894209 |
| 40 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.87894209 |
| 41 | Blue sclerae (HP:0000592) | 2.80910502 |
| 42 | Abnormality of glycolipid metabolism (HP:0010969) | 2.77678301 |
| 43 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.77678301 |
| 44 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.77678301 |
| 45 | Dilatation of the ascending aorta (HP:0005111) | 2.75475400 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.72167345 |
| 47 | Stomatitis (HP:0010280) | 2.71139345 |
| 48 | Wormian bones (HP:0002645) | 2.64373144 |
| 49 | Recurrent sinusitis (HP:0011108) | 2.63970144 |
| 50 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.61681408 |
| 51 | Nuclear cataract (HP:0100018) | 2.59519104 |
| 52 | Spondylolisthesis (HP:0003302) | 2.57482429 |
| 53 | Purpura (HP:0000979) | 2.57370637 |
| 54 | Glomerulonephritis (HP:0000099) | 2.55825834 |
| 55 | Gingivitis (HP:0000230) | 2.54663655 |
| 56 | Interstitial pulmonary disease (HP:0006530) | 2.52192299 |
| 57 | Genu recurvatum (HP:0002816) | 2.48521099 |
| 58 | Beaking of vertebral bodies (HP:0004568) | 2.48051647 |
| 59 | Abnormality of the acetabulum (HP:0003170) | 2.47789052 |
| 60 | Neurofibrillary tangles (HP:0002185) | 2.45986805 |
| 61 | Chronic obstructive pulmonary disease (HP:0006510) | 2.43847174 |
| 62 | Obstructive lung disease (HP:0006536) | 2.43847174 |
| 63 | Joint stiffness (HP:0001387) | 2.41182466 |
| 64 | Abnormality of dentin (HP:0010299) | 2.40119837 |
| 65 | Wrist flexion contracture (HP:0001239) | 2.38677134 |
| 66 | Abnormality of the anterior horn cell (HP:0006802) | 2.38478378 |
| 67 | Degeneration of anterior horn cells (HP:0002398) | 2.38478378 |
| 68 | Myocardial infarction (HP:0001658) | 2.35989446 |
| 69 | Increased serum ferritin (HP:0003281) | 2.35625417 |
| 70 | Spinal muscular atrophy (HP:0007269) | 2.31262434 |
| 71 | Hepatosplenomegaly (HP:0001433) | 2.30486802 |
| 72 | Bladder diverticulum (HP:0000015) | 2.30395629 |
| 73 | Urticaria (HP:0001025) | 2.29953735 |
| 74 | Bronchitis (HP:0012387) | 2.28515507 |
| 75 | Hand muscle atrophy (HP:0009130) | 2.27764840 |
| 76 | Progressive neurologic deterioration (HP:0002344) | 2.27431062 |
| 77 | Pulmonary infiltrates (HP:0002113) | 2.25584830 |
| 78 | Breech presentation (HP:0001623) | 2.25440746 |
| 79 | Short nail (HP:0001799) | 2.24827969 |
| 80 | Recurrent fungal infections (HP:0002841) | 2.23989247 |
| 81 | Axonal loss (HP:0003447) | 2.23548587 |
| 82 | Neonatal short-limb short stature (HP:0008921) | 2.23209492 |
| 83 | Autoimmune thrombocytopenia (HP:0001973) | 2.23141279 |
| 84 | Atrophic scars (HP:0001075) | 2.23025048 |
| 85 | Malnutrition (HP:0004395) | 2.22493842 |
| 86 | Orchitis (HP:0100796) | 2.21023204 |
| 87 | Abnormal delivery (HP:0001787) | 2.20132083 |
| 88 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.20062323 |
| 89 | Recurrent cutaneous fungal infections (HP:0011370) | 2.20062323 |
| 90 | Premature loss of primary teeth (HP:0006323) | 2.19901980 |
| 91 | Vascular tortuosity (HP:0004948) | 2.19083281 |
| 92 | Abnormality of the peritoneum (HP:0002585) | 2.12640731 |
| 93 | Thin bony cortex (HP:0002753) | 2.12553256 |
| 94 | Follicular hyperkeratosis (HP:0007502) | 2.11026788 |
| 95 | Chronic otitis media (HP:0000389) | 2.10674590 |
| 96 | Metaphyseal cupping (HP:0003021) | 2.08490386 |
| 97 | Mutism (HP:0002300) | 2.06887012 |
| 98 | Vasculitis (HP:0002633) | 2.05033627 |
| 99 | Thick nail (HP:0001805) | 2.05012645 |
| 100 | Keratoconjunctivitis sicca (HP:0001097) | 2.05003461 |
| 101 | Hemoptysis (HP:0002105) | 2.04507901 |
| 102 | Meningitis (HP:0001287) | 2.03069398 |
| 103 | Broad metatarsal (HP:0001783) | 2.02776310 |
| 104 | Ulnar bowing (HP:0003031) | 2.01389213 |
| 105 | Hematochezia (HP:0002573) | 2.00915382 |
| 106 | Myositis (HP:0100614) | 2.00027588 |
| 107 | Complement deficiency (HP:0004431) | 1.98823003 |
| 108 | Neuronal loss in central nervous system (HP:0002529) | 1.97211645 |
| 109 | Abnormality of the odontoid process (HP:0003310) | 1.97067267 |
| 110 | Distal upper limb amyotrophy (HP:0007149) | 1.96433971 |
| 111 | Upper limb amyotrophy (HP:0009129) | 1.96433971 |
| 112 | Platyspondyly (HP:0000926) | 1.95941734 |
| 113 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.95920961 |
| 114 | Asymmetric septal hypertrophy (HP:0001670) | 1.95781134 |
| 115 | Ovoid vertebral bodies (HP:0003300) | 1.94965066 |
| 116 | Chronic sinusitis (HP:0011109) | 1.94812950 |
| 117 | Recurrent otitis media (HP:0000403) | 1.94666877 |
| 118 | Poor head control (HP:0002421) | 1.94291439 |
| 119 | Recurrent abscess formation (HP:0002722) | 1.93595947 |
| 120 | Recurrent viral infections (HP:0004429) | 1.92637732 |
| 121 | Coxa vara (HP:0002812) | 1.92518579 |
| 122 | Nonimmune hydrops fetalis (HP:0001790) | 1.92198757 |
| 123 | Abnormality of iron homeostasis (HP:0011031) | 1.91726327 |
| 124 | Abnormality of complement system (HP:0005339) | 1.91549082 |
| 125 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.91239340 |
| 126 | Petechiae (HP:0000967) | 1.90600593 |
| 127 | Increased CSF protein (HP:0002922) | 1.90315524 |
| 128 | Mitral valve prolapse (HP:0001634) | 1.88741322 |
| 129 | Abnormality of skull ossification (HP:0002703) | 1.88341143 |
| 130 | Tetraparesis (HP:0002273) | 1.88039536 |
| 131 | Diminished motivation (HP:0000745) | 1.87073124 |
| 132 | Pathologic fracture (HP:0002756) | 1.86867143 |
| 133 | Apathy (HP:0000741) | 1.85808475 |
| 134 | Abnormality of macrophages (HP:0004311) | 1.85588139 |
| 135 | Aneurysm (HP:0002617) | 1.85220625 |
| 136 | Basal ganglia calcification (HP:0002135) | 1.84063266 |
| 137 | Recurrent bronchitis (HP:0002837) | 1.82879298 |
| 138 | Keratoconjunctivitis (HP:0001096) | 1.82379888 |
| 139 | Syringomyelia (HP:0003396) | 1.80375662 |
| 140 | Spinal cord lesions (HP:0100561) | 1.80375662 |
| 141 | Restrictive lung disease (HP:0002091) | 1.79652162 |
| 142 | Cerebral inclusion bodies (HP:0100314) | 1.79084546 |
| 143 | Eczematoid dermatitis (HP:0000976) | 1.78797672 |
| 144 | Spinal rigidity (HP:0003306) | 1.78299269 |
| 145 | Cupped ribs (HP:0000887) | 1.78002064 |
| 146 | Fragile skin (HP:0001030) | 1.77878981 |
| 147 | Hypoplasia of the odontoid process (HP:0003311) | 1.77558969 |
| 148 | Selective tooth agenesis (HP:0001592) | 1.76772269 |
| 149 | Elbow flexion contracture (HP:0002987) | 1.75730976 |
| 150 | Abnormality of proline metabolism (HP:0010907) | 1.75211694 |
| 151 | Hydroxyprolinuria (HP:0003080) | 1.75211694 |
| 152 | Alopecia of scalp (HP:0002293) | 1.74703539 |
| 153 | Pustule (HP:0200039) | 1.74166210 |
| 154 | Spontaneous hematomas (HP:0007420) | 1.74103275 |
| 155 | Gastrointestinal infarctions (HP:0005244) | 1.74013651 |
| 156 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.73709988 |
| 157 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.73077262 |
| 158 | Vertebral hypoplasia (HP:0008417) | 1.73077262 |
| 159 | Polyneuropathy (HP:0001271) | 1.71880785 |
| 160 | Arterial tortuosity (HP:0005116) | 1.70926439 |
| 161 | Upper motor neuron abnormality (HP:0002127) | 1.70240589 |
| 162 | Abnormal cartilage morphology (HP:0002763) | 1.69795603 |
| 163 | Hypergammaglobulinemia (HP:0010702) | 1.69661163 |
| 164 | Recurrent bacterial skin infections (HP:0005406) | 1.69186072 |
| 165 | Osteomyelitis (HP:0002754) | 1.68833782 |
| 166 | Thoracic kyphosis (HP:0002942) | 1.68628133 |
| 167 | Severe short stature (HP:0003510) | 1.68304700 |
| 168 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.68223069 |
| 169 | Hyperextensible skin (HP:0000974) | 1.66510521 |
| 170 | Joint laxity (HP:0001388) | 1.65525396 |
| 171 | Slender long bone (HP:0003100) | 1.63753125 |
| 172 | Camptodactyly of toe (HP:0001836) | 1.63331738 |
| 173 | Agnosia (HP:0010524) | 1.63256773 |
| 174 | Optic neuritis (HP:0100653) | 1.62965808 |
| 175 | Retrobulbar optic neuritis (HP:0100654) | 1.62965808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.83598512 |
| 2 | ERN1 | 3.40760080 |
| 3 | TRIB3 | 2.70626321 |
| 4 | DDR2 | 2.40459419 |
| 5 | PRPF4B | 2.27202556 |
| 6 | EPHA2 | 2.17779837 |
| 7 | MAPK15 | 2.10664313 |
| 8 | PKN2 | 1.97016276 |
| 9 | MATK | 1.93557616 |
| 10 | RPS6KA4 | 1.93037611 |
| 11 | FGR | 1.91863659 |
| 12 | GRK7 | 1.90310521 |
| 13 | PDGFRA | 1.87505882 |
| 14 | PIM2 | 1.83141467 |
| 15 | CDK12 | 1.80374326 |
| 16 | FLT3 | 1.79613137 |
| 17 | TTN | 1.68339201 |
| 18 | NME2 | 1.63177701 |
| 19 | STK38L | 1.62112403 |
| 20 | BMPR2 | 1.60268251 |
| 21 | STK3 | 1.58912443 |
| 22 | TBK1 | 1.56301814 |
| 23 | LATS1 | 1.55725432 |
| 24 | MAP3K14 | 1.54247178 |
| 25 | MAP4K1 | 1.53510428 |
| 26 | NEK9 | 1.52623035 |
| 27 | WEE1 | 1.52472002 |
| 28 | MAP3K13 | 1.51973666 |
| 29 | PASK | 1.50206090 |
| 30 | MST4 | 1.49464600 |
| 31 | BMX | 1.48812507 |
| 32 | PAK4 | 1.47422238 |
| 33 | IRAK3 | 1.46140738 |
| 34 | IKBKE | 1.45379707 |
| 35 | BRSK2 | 1.45026936 |
| 36 | MET | 1.45013164 |
| 37 | TAOK3 | 1.43358370 |
| 38 | NEK2 | 1.42283303 |
| 39 | FES | 1.41121001 |
| 40 | TAOK2 | 1.41038234 |
| 41 | BUB1 | 1.40368211 |
| 42 | TAOK1 | 1.38851599 |
| 43 | IKBKB | 1.38414024 |
| 44 | CHUK | 1.32873393 |
| 45 | TYK2 | 1.31340305 |
| 46 | SCYL2 | 1.30914876 |
| 47 | TESK1 | 1.27724086 |
| 48 | MAP3K11 | 1.26026248 |
| 49 | LATS2 | 1.25228237 |
| 50 | EPHB1 | 1.24243483 |
| 51 | NEK1 | 1.23892924 |
| 52 | KIT | 1.21606783 |
| 53 | EPHA3 | 1.20521984 |
| 54 | CDC42BPA | 1.20276388 |
| 55 | JAK3 | 1.19048651 |
| 56 | STK10 | 1.19019309 |
| 57 | LYN | 1.17680955 |
| 58 | TTK | 1.15161664 |
| 59 | MAP3K2 | 1.14849257 |
| 60 | MAP3K1 | 1.12700775 |
| 61 | LRRK2 | 1.12138271 |
| 62 | MAP3K3 | 1.10639978 |
| 63 | MST1R | 1.10328272 |
| 64 | FGFR4 | 1.09903974 |
| 65 | SYK | 1.09052527 |
| 66 | PTK2 | 1.08546278 |
| 67 | STK24 | 1.08003520 |
| 68 | PIM1 | 1.07970846 |
| 69 | GRK6 | 1.06955397 |
| 70 | MAP3K8 | 1.05860801 |
| 71 | TGFBR2 | 1.05034525 |
| 72 | SIK1 | 1.03941465 |
| 73 | HCK | 0.99328490 |
| 74 | RIPK1 | 0.98962959 |
| 75 | TRPM7 | 0.98809598 |
| 76 | TESK2 | 0.98214035 |
| 77 | BTK | 0.97495275 |
| 78 | JAK2 | 0.97043874 |
| 79 | IRAK1 | 0.95122633 |
| 80 | PTK6 | 0.94784419 |
| 81 | SIK3 | 0.93243414 |
| 82 | CDK6 | 0.92737369 |
| 83 | PLK1 | 0.87798857 |
| 84 | EIF2AK1 | 0.85981605 |
| 85 | ACVR1B | 0.85789448 |
| 86 | CDK7 | 0.85611635 |
| 87 | SMG1 | 0.84577479 |
| 88 | PAK2 | 0.82617910 |
| 89 | MTOR | 0.81425336 |
| 90 | ERBB3 | 0.80935873 |
| 91 | MAP2K3 | 0.80660387 |
| 92 | EEF2K | 0.80502634 |
| 93 | ARAF | 0.78934311 |
| 94 | ABL2 | 0.78203316 |
| 95 | TXK | 0.78180995 |
| 96 | MOS | 0.78052653 |
| 97 | PDPK1 | 0.77905017 |
| 98 | LCK | 0.77508945 |
| 99 | BLK | 0.76854187 |
| 100 | JAK1 | 0.76693495 |
| 101 | KSR2 | 0.72729891 |
| 102 | ZAP70 | 0.72284064 |
| 103 | IRAK2 | 0.71511157 |
| 104 | YES1 | 0.71497638 |
| 105 | EIF2AK3 | 0.70321640 |
| 106 | AURKB | 0.70245330 |
| 107 | TGFBR1 | 0.69732377 |
| 108 | MAPK7 | 0.69520187 |
| 109 | CSF1R | 0.69120818 |
| 110 | PLK3 | 0.68458037 |
| 111 | TNK2 | 0.68351599 |
| 112 | MARK3 | 0.66332393 |
| 113 | EPHB2 | 0.65762543 |
| 114 | CAMKK2 | 0.64976928 |
| 115 | BRSK1 | 0.63296972 |
| 116 | DYRK1B | 0.61254014 |
| 117 | PBK | 0.60170869 |
| 118 | MAP3K10 | 0.59503663 |
| 119 | TEC | 0.58836358 |
| 120 | MAP3K5 | 0.58236783 |
| 121 | ITK | 0.57643183 |
| 122 | ZAK | 0.57594687 |
| 123 | FER | 0.55961650 |
| 124 | MELK | 0.55667195 |
| 125 | PDK1 | 0.54995687 |
| 126 | STK4 | 0.54633964 |
| 127 | ATR | 0.54593618 |
| 128 | MAPKAPK3 | 0.54457998 |
| 129 | CHEK2 | 0.54030374 |
| 130 | MAP3K6 | 0.53881721 |
| 131 | CDC7 | 0.53552166 |
| 132 | MAPKAPK2 | 0.52659318 |
| 133 | DYRK3 | 0.51739292 |
| 134 | CAMK1D | 0.51707084 |
| 135 | PAK1 | 0.50254683 |
| 136 | ABL1 | 0.49582510 |
| 137 | CDK4 | 0.49413631 |
| 138 | PRKCD | 0.48872678 |
| 139 | BRAF | 0.48054668 |
| 140 | CSK | 0.47085557 |
| 141 | IRAK4 | 0.46853125 |
| 142 | FGFR1 | 0.46198651 |
| 143 | FGFR3 | 0.44403422 |
| 144 | PLK4 | 0.44162961 |
| 145 | FYN | 0.44127596 |
| 146 | EIF2AK2 | 0.42529022 |
| 147 | PTK2B | 0.42379089 |
| 148 | MARK2 | 0.41628063 |
| 149 | MAPK12 | 0.41279723 |
| 150 | PDGFRB | 0.40581648 |
| 151 | PDK2 | 0.39175865 |
| 152 | PRKD2 | 0.38963646 |
| 153 | RPS6KA2 | 0.36592779 |
| 154 | MAP2K6 | 0.36555084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.02635139 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 2.85746572 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.51249034 |
| 4 | Asthma_Homo sapiens_hsa05310 | 2.51074240 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.38651642 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.07938318 |
| 7 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.99199257 |
| 8 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.97737140 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.96048142 |
| 10 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.90103965 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.85434317 |
| 12 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.83512355 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 1.72906999 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69990191 |
| 15 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.61043229 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60441345 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.54471800 |
| 18 | Cell cycle_Homo sapiens_hsa04110 | 1.50527410 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.49732313 |
| 20 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.47338041 |
| 21 | Apoptosis_Homo sapiens_hsa04210 | 1.43771867 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.40710317 |
| 23 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.37828845 |
| 24 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.34545000 |
| 25 | Phagosome_Homo sapiens_hsa04145 | 1.33606969 |
| 26 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.31114248 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.24541166 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.21478147 |
| 29 | Bladder cancer_Homo sapiens_hsa05219 | 1.21475087 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.18364511 |
| 31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.18225687 |
| 32 | DNA replication_Homo sapiens_hsa03030 | 1.18092014 |
| 33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.15923171 |
| 34 | Tuberculosis_Homo sapiens_hsa05152 | 1.12927675 |
| 35 | RNA transport_Homo sapiens_hsa03013 | 1.12268454 |
| 36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.11050318 |
| 37 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.10676160 |
| 38 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.09353563 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.08443003 |
| 40 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.08219970 |
| 41 | Proteasome_Homo sapiens_hsa03050 | 1.05301365 |
| 42 | Galactose metabolism_Homo sapiens_hsa00052 | 1.05199157 |
| 43 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.05110814 |
| 44 | Base excision repair_Homo sapiens_hsa03410 | 1.03689943 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03296311 |
| 46 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.02964784 |
| 47 | Focal adhesion_Homo sapiens_hsa04510 | 1.02790103 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02194752 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02004631 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01815144 |
| 51 | Pertussis_Homo sapiens_hsa05133 | 1.01532376 |
| 52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01406116 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01094292 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 1.00940389 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.99370917 |
| 56 | Adherens junction_Homo sapiens_hsa04520 | 0.99182793 |
| 57 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.98541901 |
| 58 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.95644048 |
| 59 | Amoebiasis_Homo sapiens_hsa05146 | 0.94232058 |
| 60 | Mismatch repair_Homo sapiens_hsa03430 | 0.92874742 |
| 61 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.91569744 |
| 62 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.90772420 |
| 63 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.90679573 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90075060 |
| 65 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.89854660 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88965469 |
| 67 | Measles_Homo sapiens_hsa05162 | 0.88332213 |
| 68 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.86559945 |
| 69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86387259 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86062556 |
| 71 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84058260 |
| 72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.82438952 |
| 73 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81007431 |
| 74 | Hepatitis B_Homo sapiens_hsa05161 | 0.80237222 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79791570 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.77798896 |
| 77 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.76194410 |
| 78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75569574 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75319293 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74530703 |
| 81 | Influenza A_Homo sapiens_hsa05164 | 0.73479037 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73369958 |
| 83 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.72667826 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70945244 |
| 85 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69663928 |
| 86 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.68695700 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.67846665 |
| 88 | Histidine metabolism_Homo sapiens_hsa00340 | 0.67498057 |
| 89 | Protein export_Homo sapiens_hsa03060 | 0.63734140 |
| 90 | Prostate cancer_Homo sapiens_hsa05215 | 0.63312184 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62716129 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62278854 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60724027 |
| 94 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.60207601 |
| 95 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.59694148 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.59282829 |
| 97 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.58617140 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58168410 |
| 99 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.57851750 |
| 100 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56623768 |
| 101 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.56487512 |
| 102 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.56279013 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56228965 |
| 104 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.53715460 |
| 105 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52875013 |
| 106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52246409 |
| 107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.51350452 |
| 108 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51275598 |
| 109 | Melanoma_Homo sapiens_hsa05218 | 0.50758609 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50059131 |
| 111 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.49972349 |
| 112 | Salmonella infection_Homo sapiens_hsa05132 | 0.49630125 |
| 113 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.48175003 |
| 114 | Homologous recombination_Homo sapiens_hsa03440 | 0.48060494 |
| 115 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47417382 |
| 116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47094833 |
| 117 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.46933607 |
| 118 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.46870726 |
| 119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45479813 |
| 120 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.45164411 |
| 121 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44974707 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44436699 |
| 123 | Endocytosis_Homo sapiens_hsa04144 | 0.42794816 |
| 124 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.42645059 |
| 125 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.42225827 |
| 126 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.41860832 |
| 127 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.41406779 |
| 128 | Allograft rejection_Homo sapiens_hsa05330 | 0.40196552 |
| 129 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39924457 |
| 130 | Mineral absorption_Homo sapiens_hsa04978 | 0.35661864 |
| 131 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35563233 |
| 132 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.34049712 |
| 133 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.32923650 |
| 134 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32386564 |
| 135 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30751343 |
| 136 | Platelet activation_Homo sapiens_hsa04611 | 0.30595613 |
| 137 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.24354671 |
| 138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.24243421 |
| 139 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.23569403 |
| 140 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.23053721 |
| 141 | Insulin resistance_Homo sapiens_hsa04931 | 0.21642232 |

